Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Patent
1998-08-28
2000-11-07
Bawa, Raj
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
424 46, 514851, 514 52, A61K 912
Patent
active
061432792
ABSTRACT:
Compounds of Formula I: ##STR1## wherein: X.sub.1, and X.sub.2 are each independently either O.sup.- or S.sup.- ;
REFERENCES:
patent: 3313813 (1967-04-01), Cragoe et al.
patent: 3846402 (1974-11-01), Eckstein et al.
patent: 4058601 (1977-11-01), Hata et al.
patent: 4501729 (1985-02-01), Boucher et al.
patent: 5292498 (1994-03-01), Boucher, Jr.
patent: 5420116 (1995-05-01), Puchelle et al.
patent: 5628984 (1997-05-01), Boucher, Jr.
patent: 5635160 (1997-06-01), Stutts, III et al.
patent: 5656256 (1997-08-01), Boucher et al.
Eric A. Barnard; Hexokinases from Yeast, Methods in Enzymology 42:6-20 (1975).
Brown et al.; Evidence that UTP and ATP Regulate Phospholipase C through a Common Extracellular 5'-Nucelotide Receptor in Human Airway Epithelial Cells, Molecular Pharmacology 40:648-655.
Chang et al.; Molecular Cloning and Functional Analysis of a Novel P.sub.2 Nuecloetide Receptor, The Journal of Biological Chemistry, 270, No. 44:26152-26158.
S.H. Donaldson et al; In Vivo Regulation of ATP Levels in Human Nasal Epithelia, Pediatric Pulmonology Supp.; 13, 290 (Abstract No. 286) (1996).
Erb et al; Site-directed Mutagenesis of P.sub.2u Purinoceptors, The Journal of Biological Chemistry 270:4185-4188 (1995).
Goody et al; Thiophasphate Analogs of Nucleoside Di- and Triphosphates, Journal of the American Chemical Society 93:6252-6258 (1971).
Knowles et al; Activation by Extracellular Nucleotides of Chloride Secretion in the Airway Epithelia of Patients with Cystic Fibrosis, New England Journal of Medicine, 325:533-538 (Aug. 22, 1991).
Knowles et al; Extracellular ATP and UTP Induce Chloride Secretion in Nasal Epithelia of Cystic Fibrosis Patients and Normal Subject in vivo, Chest 101:60S-63S (Mar. 1992 Supplement).
Knowles et al; Abnormal Ion Permeation Through Cystic Fibrosis Respiratory Epithelium Science 221:1067-1069 (1983).
Knowles et al; Relative Ion Permeability of Normal and Cystic Fibrosis Nasal Epithelium, J. Clinical Invest. 71:1410-1417 (May 1983).
Larsen et al; Cation Transport by Sweat Ducts in Primary Culture, Ionic Mechanism of Cholinergically Evoked Current Oscillations Journal of Physiology 424:109-131 (1990).
Lazarowski et al; Identification of a Uridine Nucleotide-selective G-protein-linked Receptor that Activates Phospholipase C, The Journal of Biological Chemistry 269(11830-11836) (1994).
Lazarowski et al; Pharmacological selectivity of the cloned human P.sub.2u -puriniceptor potent activation by diadenosine tetraphosphate Br. J. Pharmacol. 116:1619-1627 (1995).
Lazarowski et al; Enzymatic synthesis of UTP.sub..gamma. S, a potent hydrolysis resistant agonist of P.sub.2u- purinoceptors, British Journal of Pharmacology 117:203-209 (1996).
Lazarowski et al; Mucosal-Restricted P.sub.2u -Receptor Independent Action of UDP on Human Nasal Epithelial Cells; Pediatric Pulmonology Supp 13, 290(Abstract No. 292)(1996).
Nakahata et al.; Regulation of inositol trisphosphate accumulation by muscarinic cholinergic and H.sub.1 -histamine receptors on human astrocytoma cells, Biochem J. 241:337-344 (1987).
Mason et al; Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium Br. J. Pharmacol. 103:1649-1656 (1991).
Nicholas et al; Uridine Nucleotide Selectivity of Three Phospholipase C-Activating P.sub.2 Receptors: Identification of a UDP-Selective, a UTP-Selective, and an ATP- and UTP-Specific Receptor Molecular Pharmacology, 50:224-229 (1996).
Olivier et al.; Acute Safety and Effects on Mucociliary Clearance of Aerosolized Uridine 5'-Triphosphate .+-.Amiloride in Normal Human Adults Am j Respir Crit Care Med 154:217-223 (1996).
Paradiso et al; Membrane-restricted regulation of Ca.sup.2+ release and influx in polarized epithelia Nature 377:643-646 (Oct. 19, 1995).
Parr et al; Cloning and expression of a human P.sub.2u nucleotide receptor, a target for cystic fibrosis pharmacotherapy Proc. Natl. Acad. Sci. USA 91:3275-3279 (Apr. 1994).
Stutts et al; Multiple modes of regulation of airway epithelial chloride secretion by extracellular ATP American Physiological Society 267:C1442-C1451(1994).
Wu et al; Growth and Differentiation of Human Nasal Epithelial Cells in Culture, Am Rev Respir Dis 132:311-320 (1985).
Boucher, Jr. Richard C.
Croom Dallas
Dougherty Robert
Pendergast William
Rideout Janet L.
Bawa Raj
Inspire Pharmaceuticals Inc.
The University of North Carolina at Chapel Hill
LandOfFree
Uridine 5'-diphosphate and analogs useful for treating lung dise does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uridine 5'-diphosphate and analogs useful for treating lung dise, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uridine 5'-diphosphate and analogs useful for treating lung dise will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1637970